Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Hematopoietic stem cell response to acute thrombocytopenia requires signaling through distinct receptor tyrosine kinases.

Ramasz B, Krüger A, Reinhardt J, Sinha A, Gerlach M, Gerbaulet A, Reinhardt S, Dahl A, Chavakis T, Wielockx B, Grinenko T.

Blood. 2019 Sep 26;134(13):1046-1058. doi: 10.1182/blood.2019000721. Epub 2019 Aug 21.

PMID:
31434705
2.

Hematopoietic Stem Cell Dynamics Are Regulated by Progenitor Demand: Lessons from a Quantitative Modeling Approach.

Klose M, Florian MC, Gerbaulet A, Geiger H, Glauche I.

Stem Cells. 2019 Jul;37(7):948-957. doi: 10.1002/stem.3005. Epub 2019 Apr 3.

PMID:
30897261
3.

STING-associated lung disease in mice relies on T cells but not type I interferon.

Luksch H, Stinson WA, Platt DJ, Qian W, Kalugotla G, Miner CA, Bennion BG, Gerbaulet A, Rösen-Wolff A, Miner JJ.

J Allergy Clin Immunol. 2019 Jul;144(1):254-266.e8. doi: 10.1016/j.jaci.2019.01.044. Epub 2019 Feb 14.

PMID:
30772497
4.

Tonic Signaling and Its Effects on Lymphopoiesis of CAR-Armed Hematopoietic Stem and Progenitor Cells.

Albert S, Koristka S, Gerbaulet A, Cartellieri M, Arndt C, Feldmann A, Berndt N, Loureiro LR, von Bonin M, Ehninger G, Eugster A, Bonifacio E, Bornhäuser M, Bachmann MP, Ehninger A.

J Immunol. 2019 Mar 15;202(6):1735-1746. doi: 10.4049/jimmunol.1801004. Epub 2019 Feb 6.

PMID:
30728213
5.

Hematopoietic stem cells can differentiate into restricted myeloid progenitors before cell division in mice.

Grinenko T, Eugster A, Thielecke L, Ramasz B, Krüger A, Dietz S, Glauche I, Gerbaulet A, von Bonin M, Basak O, Clevers H, Chavakis T, Wielockx B.

Nat Commun. 2018 May 15;9(1):1898. doi: 10.1038/s41467-018-04188-7.

6.

Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway.

Palam LR, Mali RS, Ramdas B, Srivatsan SN, Visconte V, Tiu RV, Vanhaesebroeck B, Roers A, Gerbaulet A, Xu M, Janga SC, Takemoto CM, Paczesny S, Kapur R.

JCI Insight. 2018 Feb 22;3(4). pii: 94679. doi: 10.1172/jci.insight.94679. eCollection 2018 Feb 22.

7.

Lack of Trex1 Causes Systemic Autoimmunity despite the Presence of Antiretroviral Drugs.

Achleitner M, Kleefisch M, Hennig A, Peschke K, Polikarpova A, Oertel R, Gabriel B, Schulze L, Lindeman D, Gerbaulet A, Fiebig U, Lee-Kirsch MA, Roers A, Behrendt R.

J Immunol. 2017 Oct 1;199(7):2261-2269. doi: 10.4049/jimmunol.1700714. Epub 2017 Aug 23.

8.

SCA-1 Expression Level Identifies Quiescent Hematopoietic Stem and Progenitor Cells.

Morcos MNF, Schoedel KB, Hoppe A, Behrendt R, Basak O, Clevers HC, Roers A, Gerbaulet A.

Stem Cell Reports. 2017 Jun 6;8(6):1472-1478. doi: 10.1016/j.stemcr.2017.04.012. Epub 2017 May 11.

9.

Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice.

Weidemann RR, Behrendt R, Schoedel KB, Müller W, Roers A, Gerbaulet A.

Exp Hematol. 2017 Jan;45:45-55.e6. doi: 10.1016/j.exphem.2016.09.005. Epub 2016 Sep 21.

PMID:
27664314
10.

Loss of Trex1 in Dendritic Cells Is Sufficient To Trigger Systemic Autoimmunity.

Peschke K, Achleitner M, Frenzel K, Gerbaulet A, Ada SR, Zeller N, Lienenklaus S, Lesche M, Poulet C, Naumann R, Dahl A, Ravens U, Günther C, Müller W, Knobeloch KP, Prinz M, Roers A, Behrendt R.

J Immunol. 2016 Sep 15;197(6):2157-66. doi: 10.4049/jimmunol.1600722. Epub 2016 Aug 10.

11.

The bulk of the hematopoietic stem cell population is dispensable for murine steady-state and stress hematopoiesis.

Schoedel KB, Morcos MNF, Zerjatke T, Roeder I, Grinenko T, Voehringer D, Göthert JR, Waskow C, Roers A, Gerbaulet A.

Blood. 2016 Nov 10;128(19):2285-2296. doi: 10.1182/blood-2016-03-706010. Epub 2016 Jun 29.

PMID:
27357698
12.

Clinical Experience with Pulse Dose Rate Brachytherapy for Conservative Treatment of Penile Carcinoma and Comparison with Historical Data of Low Dose Rate Brachytherapy.

Kamsu-Kom L, Bidault F, Mazeron R, Baratiny C, Martin V, Maroun P, Dumas I, Guemnie-Tafo A, Martinetti F, Gerbaulet A, Chargari C, Haie-Meder C.

Clin Oncol (R Coll Radiol). 2015 Jul;27(7):387-93. doi: 10.1016/j.clon.2015.03.010. Epub 2015 May 21.

PMID:
26003455
13.

Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosis.

De Vita S, Schneider RK, Garcia M, Wood J, Gavillet M, Ebert BL, Gerbaulet A, Roers A, Levine RL, Mullally A, Williams DA.

PLoS One. 2014 May 2;9(5):e96209. doi: 10.1371/journal.pone.0096209. eCollection 2014.

14.

Volumetric evaluation of an alternative bladder point in brachytherapy for locally advanced cervical cancer.

Mazeron R, Gilmore J, Champoudry J, Dumas I, Helou J, Maroun P, Martinetti F, Gerbaulet A, Haie-Meder C.

Strahlenther Onkol. 2014 Jan;190(1):41-7. doi: 10.1007/s00066-013-0463-6. Epub 2013 Nov 17.

PMID:
24240504
15.

Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response.

Behrendt R, Schumann T, Gerbaulet A, Nguyen LA, Schubert N, Alexopoulou D, Berka U, Lienenklaus S, Peschke K, Gibbert K, Wittmann S, Lindemann D, Weiss S, Dahl A, Naumann R, Dittmer U, Kim B, Mueller W, Gramberg T, Roers A.

Cell Rep. 2013 Aug 29;4(4):689-96. doi: 10.1016/j.celrep.2013.07.037. Epub 2013 Aug 22.

16.

Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis.

Rabenhorst A, Christopeit B, Leja S, Gerbaulet A, Kleiner S, Förster A, Raap U, Wickenhauser C, Hartmann K.

J Allergy Clin Immunol. 2013 Nov;132(5):1234-1237.e7. doi: 10.1016/j.jaci.2013.06.019. Epub 2013 Jul 31. No abstract available.

PMID:
23910691
17.

[Evolution of prostate cancer brachytherapy].

Hannoun-Levi JM, Chevallier D, Cosset JM, Gerbaulet A.

Bull Cancer. 2012 Dec;99(12):1175-81. doi: 10.1684/bdc.2012.1668. Review. French.

18.

Clear cell adenocarcinoma of the female genital tract: long-term outcome and fertility aspects after brachytherapy aimed at a conservative treatment.

Magné N, Chargari C, Levy A, Rodriguez C, De Vos V, Gerbaulet A, Duvillard P, Morice P, Haie-Meder C.

Int J Gynecol Cancer. 2012 Oct;22(8):1378-82.

PMID:
22932263
19.

Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit.

Gerbaulet A, Wickenhauser C, Scholten J, Peschke K, Drube S, Horny HP, Kamradt T, Naumann R, Müller W, Krieg T, Waskow C, Hartmann K, Roers A.

Blood. 2011 Feb 10;117(6):2012-21. doi: 10.1182/blood-2008-11-189605. Epub 2010 Dec 9.

PMID:
21148330
20.

The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.

Drube S, Heink S, Walter S, Löhn T, Grusser M, Gerbaulet A, Berod L, Schons J, Dudeck A, Freitag J, Grotha S, Reich D, Rudeschko O, Norgauer J, Hartmann K, Roers A, Kamradt T.

Blood. 2010 May 13;115(19):3899-906. doi: 10.1182/blood-2009-10-247411. Epub 2010 Mar 3.

PMID:
20200353
21.

Technical aspects and perspectives of the vaginal mold applicator for brachytherapy of gynecologic malignancies.

Magné N, Chargari C, SanFilippo N, Messai T, Gerbaulet A, Haie-Meder C.

Brachytherapy. 2010 Jul-Sep;9(3):274-7. doi: 10.1016/j.brachy.2009.08.014. Epub 2010 Feb 13.

PMID:
20153985
22.

Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX).

de Crevoisier R, Slimane K, Sanfilippo N, Bossi A, Albano M, Dumas I, Wibault P, Fizazi K, Gerbaulet A, Haie-Meder C.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1150-6. doi: 10.1016/j.ijrobp.2008.09.054. Epub 2009 Apr 22.

PMID:
19395183
23.

Vulval and vaginal rhabdomyosarcoma in children: update and reappraisal of Institut Gustave Roussy brachytherapy experience.

Magné N, Oberlin O, Martelli H, Gerbaulet A, Chassagne D, Haie-Meder C.

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):878-83. doi: 10.1016/j.ijrobp.2008.01.034. Epub 2008 Mar 20.

PMID:
18355981
24.

Mast cell-specific Cre/loxP-mediated recombination in vivo.

Scholten J, Hartmann K, Gerbaulet A, Krieg T, Müller W, Testa G, Roers A.

Transgenic Res. 2008 Apr;17(2):307-15. Epub 2007 Oct 31.

25.

Exclusive radiotherapy for primary squamous cell carcinoma of the vagina.

de Crevoisier R, Sanfilippo N, Gerbaulet A, Morice P, Pomel C, Castaigne D, Pautier P, Lhomme C, Duvillard P, Haie-meder C.

Radiother Oncol. 2007 Dec;85(3):362-70. Epub 2007 Oct 25.

PMID:
17963909
26.

Mast cell apoptosis.

Gerbaulet A, Hartmann K, Mekori YA.

Methods Mol Biol. 2006;315:407-23.

PMID:
16110173
27.

A novel chloride channel in Drosophila melanogaster is inhibited by protons.

Schnizler K, Saeger B, Pfeffer C, Gerbaulet A, Ebbinghaus-Kintscher U, Methfessel C, Franken EM, Raming K, Wetzel CH, Saras A, Pusch H, Hatt H, Gisselmann G.

J Biol Chem. 2005 Apr 22;280(16):16254-62. Epub 2005 Feb 15.

28.

Management and clinical outcomes of pregnant patients with invasive cervical cancer.

Germann N, Haie-Meder C, Morice P, Lhomme C, Duvillard P, Hacene K, Gerbaulet A.

Ann Oncol. 2005 Mar;16(3):397-402. Epub 2005 Jan 24.

PMID:
15668263
29.

Outcome after salvage radiotherapy (brachytherapy +/- external) in patients with a vaginal recurrence from endometrial carcinomas.

Hasbini A, Haie-Meder C, Morice P, Chirat E, Duvillard P, Lhommé C, Delapierre M, Gerbaulet A.

Radiother Oncol. 2002 Oct;65(1):23-8.

PMID:
12413671
30.

Brachytherapy for T1-T2 floor-of-the-mouth cancers: the Gustave-Roussy Institute experience.

Marsiglia H, Haie-Meder C, Sasso G, Mamelle G, Gerbaulet A.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1257-63.

PMID:
11955737
31.

Radiotherapy and radical surgery for treatment of patients with bulky stage IB and II cervical carcinoma.

Morice P, Haie-Meder C, Rey A, Pautier P, Lhommé C, Gerbaulet A, Duvillard P, Castaigne D.

Int J Gynecol Cancer. 2000 May;10(3):239-246.

PMID:
11240681
32.

[Brachytherapy in the treatment of vesicoprostatic rhabdomyosarcomas in children].

Haie-Meder C, Breton-Callu C, Oberlin O, Martelli H, Audry G, Valayer J, Habrand JL, Terrier-Lacombe MJ, Gerbaulet A.

Cancer Radiother. 2000 Nov;4 Suppl 1:145s-149s. French.

PMID:
11194954
33.

Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face.

Petit JY, Avril MF, Margulis A, Chassagne D, Gerbaulet A, Duvillard P, Auperin A, Rietjens M.

Plast Reconstr Surg. 2000 Jun;105(7):2544-51.

PMID:
10845311
34.

Isolated para-aortic node involvement in stage IB/II cervical carcinoma.

Morice P, Sabourin JC, Pautier P, Gerbaulet A, Duvillard P, Castaigne D.

Eur J Gynaecol Oncol. 2000;21(2):123-5.

PMID:
10843467
35.

High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma.

Marsiglia H, Baldeyrou P, Lartigau E, Briot E, Haie-Meder C, Le Chevalier T, Sasso G, Gerbaulet A.

Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):665-72.

PMID:
10837950
36.

[Curietherapy in uterine cervix cancers: what therapeutic trends?].

Haie-Meder C, Breton C, de Crevoisier R, Gerbaulet A.

Cancer Radiother. 2000 Mar-Apr;4(2):133-9. Review. French.

PMID:
10812359
37.

Laparoscopic prophylactic oophorectomy in women with inherited risk of ovarian cancer.

Morice P, Pautier P, Mercier S, Spatz A, Lhommé C, Duvillard P, Gerbaulet A, Castaigne D.

Eur J Gynaecol Oncol. 1999;20(3):202-4.

PMID:
10410886
38.

Tumor size in cervix cancer and metastases.

Lambin P, Kramar A, Haie-Meder C, Gerbaulet A.

Radiother Oncol. 1999 Apr;51(1):95-6. No abstract available.

PMID:
10386722
39.

How can laparoscopic management assist radiation treatment in cervix carcinoma?

Gerbaulet A, Lartigau E, Haie-Meder C, Castaigne D, Morice P, Breton C, Pautier P, Duvillard P.

Radiother Oncol. 1999 Apr;51(1):9-13.

PMID:
10386711
40.

[The centenary of the discovery of radium].

Mazeron JJ, Gerbaulet A.

Cancer Radiother. 1999 Jan-Feb;3(1):19-29. French.

PMID:
10083860
41.

The centenary of discovery of radium.

Mazeron JJ, Gerbaulet A.

Radiother Oncol. 1998 Dec;49(3):205-16.

PMID:
10075253
42.

Tumour size in cancer of the cervix.

Lambin P, Kramar A, Haie-Meder C, Castaigne D, Scalliet P, Bouzy J, Malaise EP, Gerbaulet A.

Acta Oncol. 1998;37(7-8):729-34.

PMID:
10050994
43.

[Lymphatic drainage in stage IB and II cervical cancers: anatomical study and surgical deductions].

Michel G, Morice P, Castaigne D, Pautier P, Gerbaulet A, Duvillard P, Rey A.

Contracept Fertil Sex. 1998 Nov;26(11):suppl VII-XI. French. No abstract available.

PMID:
9864891
44.

How to optimize therapeutic ratio in brachytherapy of head and neck squamous cell carcinoma?

Mazeron JJ, Gerbaulet A, Simon JM, Hardiman C.

Acta Oncol. 1998;37(6):583-91.

PMID:
9860317
45.

Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes.

Morice P, Castaigne D, Haie-Meder C, Pautier P, El Hassan J, Duvillard P, Gerbaulet A, Michel G.

Fertil Steril. 1998 Nov;70(5):956-60.

PMID:
9806584
46.

Squamous cell carcinoma of the penis

Soria JC, Theodore C, Gerbaulet A.

Bull Cancer. 1998 Sep;85(9):773.

47.

[Epidermoid carcinoma of the penis].

Soria JC, Theodore C, Gerbaulet A.

Bull Cancer. 1998 Sep;85(9):773-84. Review. French.

48.

[Role of intravascular brachytherapy in the prevention of vascular restenosis after angioplasty].

Noël G, Feuvret L, Bourhis J, Pousset F, Gerbaulet A, Popowski Y, Mazeron JJ.

Cancer Radiother. 1998 Jul-Aug;2(4):325-37. Review. French.

PMID:
9755746
49.

[Prognostic factors of cancer of the endometrium and therapeutic implications].

Michel G, Morice P, Castaigne D, Lanoux P, Pautier P, Lhommé C, Gerbaulet A, Duvillard P.

Contracept Fertil Sex. 1998 Jun;26(6):452-6. French.

PMID:
9691524
50.

Fertility results after ovarian transposition for pelvic malignancies treated by external irradiation or brachytherapy.

Morice P, Thiam-Ba R, Castaigne D, Haie-Meder C, Gerbaulet A, Pautier P, Duvillard P, Michel G.

Hum Reprod. 1998 Mar;13(3):660-3.

PMID:
9572430

Supplemental Content

Loading ...
Support Center